Induced sputum and bronchial mucosal expression of interleukin-13 is not increased in chronic obstructive pulmonary disease.
BACKGROUND: The Th2 cytokine interleukin-13 (IL-13) has been implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD). We sought to examine IL-13 expression in COPD subjects in induced sputum and bronchus specimens. We hypothesized that inflammatory cells expressing IL-13 local...
Huvudupphovsmän: | , , , , , , , |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
2008
|
_version_ | 1826306765627588608 |
---|---|
author | Saha, S Mistry, V Siva, R Parker, D May, R Bradding, P Pavord, I Brightling, C |
author_facet | Saha, S Mistry, V Siva, R Parker, D May, R Bradding, P Pavord, I Brightling, C |
author_sort | Saha, S |
collection | OXFORD |
description | BACKGROUND: The Th2 cytokine interleukin-13 (IL-13) has been implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD). We sought to examine IL-13 expression in COPD subjects in induced sputum and bronchus specimens. We hypothesized that inflammatory cells expressing IL-13 localize to the airway smooth muscle bundle and bronchial glands. METHODS: Interleukin-13 was measured in sputum samples from subjects with COPD (n = 34) across a range of severity (Global initiative for chronic Obstructive Lung Disease 2-4) and controls (n = 14) using ELISA. IL-13+ cells and inflammatory cells were enumerated within surgically resected proximal airway using immunohistochemical techniques from subjects with COPD (n = 10), smoking (n = 10) and nonsmoking controls (n = 8). RESULTS: Sputum IL-13 was measurable in only 6/34 subjects with COPD and was not found in the smoking or nonsmoking control subjects. In subjects with COPD and controls there was a paucity of IL-13+ cells. The distribution of inflammatory cells within different airway compartments was similar in COPD and controls except for an increase in CD3(+) lymphocytes within bronchial glands in COPD (P = 0.04). CONCLUSIONS: Our findings do not support a role for IL-13 in COPD. However, the tissue localization of inflammatory cells to airway compartments, particularly the increase of T cells in glands in COPD may be important in disease. |
first_indexed | 2024-03-07T06:52:53Z |
format | Journal article |
id | oxford-uuid:fd1fe26a-3a8d-453e-a36b-f2aee626b87b |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T06:52:53Z |
publishDate | 2008 |
record_format | dspace |
spelling | oxford-uuid:fd1fe26a-3a8d-453e-a36b-f2aee626b87b2022-03-27T13:26:31ZInduced sputum and bronchial mucosal expression of interleukin-13 is not increased in chronic obstructive pulmonary disease.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:fd1fe26a-3a8d-453e-a36b-f2aee626b87bEnglishSymplectic Elements at Oxford2008Saha, SMistry, VSiva, RParker, DMay, RBradding, PPavord, IBrightling, CBACKGROUND: The Th2 cytokine interleukin-13 (IL-13) has been implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD). We sought to examine IL-13 expression in COPD subjects in induced sputum and bronchus specimens. We hypothesized that inflammatory cells expressing IL-13 localize to the airway smooth muscle bundle and bronchial glands. METHODS: Interleukin-13 was measured in sputum samples from subjects with COPD (n = 34) across a range of severity (Global initiative for chronic Obstructive Lung Disease 2-4) and controls (n = 14) using ELISA. IL-13+ cells and inflammatory cells were enumerated within surgically resected proximal airway using immunohistochemical techniques from subjects with COPD (n = 10), smoking (n = 10) and nonsmoking controls (n = 8). RESULTS: Sputum IL-13 was measurable in only 6/34 subjects with COPD and was not found in the smoking or nonsmoking control subjects. In subjects with COPD and controls there was a paucity of IL-13+ cells. The distribution of inflammatory cells within different airway compartments was similar in COPD and controls except for an increase in CD3(+) lymphocytes within bronchial glands in COPD (P = 0.04). CONCLUSIONS: Our findings do not support a role for IL-13 in COPD. However, the tissue localization of inflammatory cells to airway compartments, particularly the increase of T cells in glands in COPD may be important in disease. |
spellingShingle | Saha, S Mistry, V Siva, R Parker, D May, R Bradding, P Pavord, I Brightling, C Induced sputum and bronchial mucosal expression of interleukin-13 is not increased in chronic obstructive pulmonary disease. |
title | Induced sputum and bronchial mucosal expression of interleukin-13 is not increased in chronic obstructive pulmonary disease. |
title_full | Induced sputum and bronchial mucosal expression of interleukin-13 is not increased in chronic obstructive pulmonary disease. |
title_fullStr | Induced sputum and bronchial mucosal expression of interleukin-13 is not increased in chronic obstructive pulmonary disease. |
title_full_unstemmed | Induced sputum and bronchial mucosal expression of interleukin-13 is not increased in chronic obstructive pulmonary disease. |
title_short | Induced sputum and bronchial mucosal expression of interleukin-13 is not increased in chronic obstructive pulmonary disease. |
title_sort | induced sputum and bronchial mucosal expression of interleukin 13 is not increased in chronic obstructive pulmonary disease |
work_keys_str_mv | AT sahas inducedsputumandbronchialmucosalexpressionofinterleukin13isnotincreasedinchronicobstructivepulmonarydisease AT mistryv inducedsputumandbronchialmucosalexpressionofinterleukin13isnotincreasedinchronicobstructivepulmonarydisease AT sivar inducedsputumandbronchialmucosalexpressionofinterleukin13isnotincreasedinchronicobstructivepulmonarydisease AT parkerd inducedsputumandbronchialmucosalexpressionofinterleukin13isnotincreasedinchronicobstructivepulmonarydisease AT mayr inducedsputumandbronchialmucosalexpressionofinterleukin13isnotincreasedinchronicobstructivepulmonarydisease AT braddingp inducedsputumandbronchialmucosalexpressionofinterleukin13isnotincreasedinchronicobstructivepulmonarydisease AT pavordi inducedsputumandbronchialmucosalexpressionofinterleukin13isnotincreasedinchronicobstructivepulmonarydisease AT brightlingc inducedsputumandbronchialmucosalexpressionofinterleukin13isnotincreasedinchronicobstructivepulmonarydisease |